In the dynamic landscape of healthcare and biotechnology, venture capital firms play a crucial role in fueling innovations that have the potential to redefine the industry. The year 2023 has seen a myriad of venture capital firms making significant strides in investing in promising startups within the healthcare and biotech sectors. In this article, we delve into the top 10 venture capital firms in the US that are spearheading investments in this domain, supporting groundbreaking work that holds the promise of transforming lives and the industry at large.

New Enterprise Associates (NEA)

Located in Menlo Park, California, NEA has a focal point on Technology and Healthcare. With notable portfolio companies like Databricks, Genies, and Strive Health under its belt, NEA has a longstanding history of investing in healthcare. By partnering with entrepreneurs, NEA fuels growth in disruptive tech and healthcare companies, carving a niche in the venture capital realm. Boasting a remarkable $25 billion in assets under management, NEA is committed to backing early-stage companies that are set to disrupt high-growth industries.

Third Rock Ventures

Situated in Boston, Massachusetts, Third Rock Ventures is a firm rooted in Life Sciences. With a portfolio boasting names like Terremoto Biosciences, Septerna, and MyoKardia, the firm strides on a solid foundation in the life sciences sector. The firm is known for transforming breakthrough discoveries into promising new health solutions, with companies like AsherBio, Celsius, and Maze Therapeutics enriching their portfolio. Their dedicated team passionately engages in every stage of a company’s lifecycle, fostering innovation through diversity and aligning investments with a vision of inclusivity and patient-centric approaches.

Domain Associates

With its base in San Diego, California, Domain Associates focuses on Pharmaceuticals, Diagnostics, and Medical Devices. With nearly three decades of experience, the firm has notable portfolio companies like Amylin Pharmaceuticals, WindMIL Therapeutics, and ESP Pharmacy. Domain Associates continues to build successful healthcare companies, dedicating over $2.8 billion in capital towards improving human life. They place a high value on establishing trust, credibility, and valuable relationships with its portfolio companies, showcasing their long-term commitment to the startups they invest in.

OrbiMed

Hailing from New York, New York, OrbiMed has a global footprint in Global Healthcare. Portfolio highlights include Adaptive, Delfi, and Entero. OrbiMed leverages its expertise to invest across all stages of a company’s lifecycle, seeking opportunities in disruptive and innovative healthcare products. With a team of over 100 professionals managing more than $17 billion of public and private investments, OrbiMed demonstrates a substantial commitment to fostering growth trends alongside scientific innovations.

Versant Ventures

Residing in Menlo Park, California, Versant Ventures is engrossed in Healthcare. With a broad investment spectrum and notable portfolio companies like Lava Therapeutics, Foresight Visions, and Anokion, Versant Ventures stands out with its Discovery Engines. These in-house teams foster the launch of novel biotechnology companies, enriching the venture capital landscape. Versant explores all investment options including early, late, debt financing, and private equity, with over $4 billion of capital under management alongside 50 IPOs and 46 M&As, showcasing its robust investment capabilities and successful exit strategies.

New Leaf Venture Partners

Based in New York, New York, New Leaf Venture Partners navigates the realms of Biopharmaceuticals, Information Convergence, and Life Science Tools. Managing over $2 billion, the firm has a track record of fostering billion-dollar companies like PassageBio, BrightInsight, and Edgewise, with a mission to improve healthcare outcomes through innovative partnerships. With a commitment to fostering innovation using their knowledge, experience, network, and passion, New Leaf invests in over 150 different companies, making significant strides in catalyzing innovative solutions within these sectors.

PTV Healthcare Capital

From Austin, Texas, PTV Healthcare Capital emerges with a focus on Healthtech Innovation. Extending Series A+ funding and valuable expertise to disruptive medical technology companies, PTV’s notable portfolio companies include Apollo Endosurgery, Asuragen, and Intersect ENT, aiming to drive healthtech innovation. They particularly favor companies that bring disruptive medical technologies to the table, showcasing their vision for transformative healthcare solutions.

Quaker Partners

Located in Philadelphia, Pennsylvania, Quaker Partners dives into Early-stage Healthcare Startups. Though currently not making new investments, Quaker has a rich history of investing in high-impact healthcare companies like NYDHA, Rapid Micro Biosystems, and TelaBio across various verticals such as medical tools & devices, human diagnostics, healthcare services, biotechnology, and pharmaceuticals.

Abundant Venture Partners

Hailing from Chicago, Illinois, Abundant Venture Partners targets the Healthtech Sector. Offering Seed and Series A funding, the firm not only provides capital but connects portfolio companies like Ardent.io, Avia, and Cardinal Path with trusted partners to fuel growth. Although the exact investment amount is not disclosed, their focus on early-stage healthcare startups and their dedication to fostering a supportive ecosystem are evident.

BioAdvance

With its base in Philadelphia, Pennsylvania, BioAdvance focuses on Early-stage Life Science Companies within the mid-Atlantic region. Investing anywhere between $500k to $5M, BioAdvance nurtures innovation across Health IT, Diagnostics, Research Tools, Medical Devices, and Therapeutics, carving its distinct mark in the venture capital sphere.

These trailblazing venture capital firms are at the forefront of fostering innovation and growth within the healthcare and biotech sectors. Their strategic investments and unwavering support for startups are pivotal in driving the medical revolution forward, promising a brighter future for healthcare and biotechnology.

Quantum Growth Advisors provides data driven fundraising & dealflow automation services for startups, investors and service providers. To learn more about our software & services, book a consult.